汉王科技2025年年度报告详解：AI创新突破与财务表现双重压力下的投资机会与风险

一、报告核心要点与可能影响股价的重要信息

• 盈利状况持续承压：2025年度归属于上市公司股东的净利润为-1.96亿元，同比下滑77.87%，净资产收益率降至-18.79%。公司已连续三年亏损，且截至报告期末累计未弥补亏损高达2.89亿元，已不符合现金分红条件。
• 收入增长但质量承压：2025年营业收入为18.89亿元，同比增长3.96%，表明主营业务仍有增长动能，但增速放缓。
• 现金流恶化：经营活动产生的现金流量净额为-3,754万元，较去年大幅下降，显示公司在现金管理和营运能力方面面临较大压力。
• AI领域技术创新频出：
  • 全球首颗磁容触控芯片商业化试点，拥有全球唯一的单层Sensor+单芯片架构。
  • 仿生扑翼飞行器在行业应用中获得多项荣誉，入选2025年度中关村科学城AI典型案例。
  • 生物嗅觉识别技术进入产业化验证阶段，相关成果发表于国际SCI期刊。
  • 持续推进AI+行业应用，如智慧司法、数字人文、智慧医疗、智慧金融、汽车电子等赛道，多个AI模型和应用在行业落地。
• 核心业务板块表现分化：
  • 数字绘画产品海外销售份额提升，绘画平板销售高速增长。
  • 数字触控笔模组持续创新，与主流消费电子品牌合作。
  • 无纸化签批业务在传统领域需求趋于饱和，新兴场景和海外拓展进展缓慢。
  • 多模态大数据业务在智慧司法、图书馆、档案、医疗等领域保持行业领先，智慧图书馆古籍数字化领域中标金额行业第一。
  • AI智能终端产品中，墨水屏读写本保持增长，AI柯氏音电子血压计在高端市场及普惠型市场均获销量第一。
• 研发与知识产权壁垒：累计拥有有效专利1215项，发明专利454件，注册商标1816项（含海外635项），继续巩固技术与品牌壁垒。
• 无分红，资金压力大：董事会决议不进行现金分红、不送红股、不以公积金转增股本，提示投资者注意投资风险。
• 股东结构稳定但高度集中：前两大股东刘迎建、徐冬青夫妇合计持股27.23%，为公司实际控制人。

二、详细业务分析

1. 研发创新与AI布局

汉王科技以自研全栈AI能力为核心，覆盖文本、图像、音频、视频等多模态融合，布局从感知智能、认知决策到具身智能的核心技术链。报告期内AI赋能端侧产品和行业场景，优化AI对话、内容创作、会议纪要、阅读理解等功能，突破声源定位、回声消除、语音去噪等关键技术，AI会议助手端侧离线识别技术业内领先。仿生扑翼飞行器实现商业化量产，核心功能技术成熟，并获得多项行业荣誉。

2. 主营业务板块分化明显

• 笔智能交互业务：
  • 数字绘画产品以多品牌出海为主，覆盖全球100余国。新品绘画平板高速增长，满足轻量创作需求。
  • 数字触控笔芯片/模组创新推出EMR Mini方案，与主流消费电子品牌合作，推动出货量增长。
  • 无纸化签批在银行、运营商场景趋于饱和，新兴领域（医疗、司法、社保等）需求释放缓慢，海外扩展难度增加。
• 多模态大数据业务：
  • 智慧司法业务覆盖全国300余家法院、检察院等，AI“智诉助理”和“智诉宝”产品获最高法认可。
  • 智慧图书馆、古籍数字化中标金额行业领先，与国家图书馆等长期合作。
  • 智慧档案、医疗（智慧病案）、金融（AI风控视频分析）、汽车电子输入法等多领域业务持续拓展。
• AI智能终端业务：
  • AI智能读写本（墨水屏平板）市场份额持续提升，电纸书在京东、天猫销量第一。
  • AI柯氏音电子血压计在高端市场和200元区间普惠市场均获销额第一，获批北京市创新医疗器械。
  • 生物特征识别、AI视频分析等产品在泛安防、智慧康养等领域逐步落地。

3. 财务数据与股东信息

• 总资产19.30亿元，净资产9.49亿元，资产规模略有下降。
• 归属于上市公司股东的净利润为-1.96亿元，同比大幅下滑。
• 经营活动现金流净额为-3,754万元，现金流性风险加大。
• 分季度看，第四季度亏损最大，净利润为-1.05亿元，全年亏损主要集中于下半年。
• 前十大股东持股高度集中，实际控制人为刘迎建、徐冬青夫妇。

三、投资者须关注的风险与机遇

• 持续大额亏损及现金流压力：公司已连续三年亏损，且经营现金流转负，需密切关注资金链风险。
• 高研发投入与创新落地风险：尽管技术创新频出，但商业化变现周期长，需注意新技术市场接受度与收入转化风险。
• AI与硬件产品市场拓展挑战：部分产品如无纸化签批在传统市场已趋于饱和，新兴领域与海外市场开拓进展缓慢，存在增长瓶颈。
• 政策与行业景气影响：公司多项业务受政策、行业项目招投标影响较大，需关注宏观环境变动。
• 品牌和市场推广压力：医疗领域品牌影响力有待进一步提升，市场推广和下沉需持续投入。

四、结论：投资者如何应对？

汉王科技在AI感知与多模态技术、智能终端、行业应用等领域持续创新，技术壁垒和知识产权布局坚实。但公司面临持续亏损、现金流压力、部分业务增长乏力等问题。后续若AI新品商业化取得突破、现金流改善、行业大单落地，有望成为股价催化剂。反之，若亏损持续扩大、资金链紧张或新技术未能转化为实质收入，可能对股价形成压力。投资者需密切关注公司后续经营和财务表现。

免责声明：本文根据汉王科技股份有限公司2025年年度报告公开信息整理，仅供投资者参考，不构成任何投资建议。投资有风险，入市需谨慎。

English Version:

Hanvon Technology 2025 Annual Report Deep Dive: AI Innovation Amid Financial Pressures – Opportunities and Risks for Investors

I. Key Highlights & Price-Sensitive Information

• Continued Operating Losses: Net profit attributable to shareholders was -196 million RMB for 2025, a 77.87% YoY decline, with net asset return dropping to -18.79%. The company has had three consecutive years of losses and has an accumulated unmade-up loss of 289 million RMB, making it ineligible for a cash dividend.
• Revenue Grows, But With Quality Concerns: Revenue reached 1.89 billion RMB, up 3.96% YoY, showing some growth momentum but at a slower pace.
• Worsening Cash Flow: Operating cash flow was -37.5 million RMB, a sharp decline, indicating significant pressure on cash management and business operations.
• Frequent AI Technology Innovations:
  • World’s first commercialized EMC touch chip, with global exclusive single-layer sensor + single chip architecture.
  • Bionic flapping-wing flying robot gained multiple industry honors and was selected as a 2025 Zhongguancun AI showcase case.
  • Biological olfactory recognition tech entered industrial verification, with results published in international SCI journals.
  • Continued deployment of AI+ industry applications: legal, humanities, medical, finance, automotive electronics, etc. Several AI models and applications have landed in industry use.
• Mixed Performance Across Main Business Segments:
  • Digital painting products increased overseas market share, drawing tablet sales grew rapidly.
  • Digital stylus modules saw ongoing innovation and collaborations with major consumer electronics brands.
  • Paperless signing business is saturated in traditional industries; new and overseas markets are progressing slowly.
  • Multimodal big data business maintains leadership in legal, library, archive, and medical fields; leading bid sums in digital library and ancient book segments.
  • AI terminal products: e-ink reading/writing tablets grew; AI Korotkoff electronic sphygmomanometer ranked #1 in both high-end and mass markets.
• R&D and IP Barriers: Hold 1,215 valid patents, 454 invention patents, 1,816 registered trademarks (635 overseas), reinforcing technical and brand moat.
• No Dividend, High Funding Pressure: Board decided against cash dividend, bonus shares, or capital reserve transfer. Investors are advised to be cautious regarding investment risk.
• Stable but Concentrated Shareholding: Top two shareholders (Mr. Liu Yingjian and Ms. Xu Dongqing) together hold 27.23% and are actual controllers.

II. Detailed Business Analysis

1. R&D Innovation and AI Deployment

Hanvon Technology centers on in-house full-stack AI capabilities, covering text, image, audio, and video multimodal fusion, from perceptual intelligence to embodied intelligence. During the period, AI empowered more end-side products and industry scenarios, optimizing dialogue, content creation, meeting minutes, reading comprehension, and breaking through key technologies in voice localization, echo cancellation, and noise reduction. AI meeting assistant’s offline recognition is industry-leading. Bionic flapping-wing robot achieved mass production and key functions, winning multiple honors.

2. Divergence Among Main Business Segments

• Pen-Based Intelligent Interaction:
  • Digital painting products (multi-brand, 100+ countries), drawing tablets saw rapid growth.
  • Digital stylus chips/modules launched innovative EMR Mini, collaborating with major consumer electronics brands.
  • Paperless signing matured in banking/telecom; new sectors (medical, legal, social security) and overseas markets slow to scale.
• Multimodal Big Data:
  • “Smart Justice” covers 300+ courts, prosecution, etc. “Smart Lit Assistant” and “Smart Lit Treasure” products recognized by the Supreme Court.
  • Digital library and ancient book segments lead the industry, long-term partnerships with top national libraries.
  • Archives, medical (smart medical records), finance (AI video risk control), automotive input method, etc., continue to expand.
• AI Terminal Products:
  • AI reading/writing tablets (e-ink) grew market share, e-readers ranked #1 on JD.com and Tmall.
  • AI Korotkoff sphygmomanometer led both high-end and 200-yuan mass market, approved as Beijing innovative medical device.
  • Biometric, AI video analytics products deployed in security, smart elderly care, etc.

3. Financials and Shareholding

• Total assets of 1.93 billion RMB, net assets of 949 million RMB, slight asset decline.
• Net profit attributable to shareholders -196 million RMB, major YoY decline.
• Operating cash flow -37.5 million RMB, raising liquidity risk.
• Quarterly: Q4 loss was largest at -105 million RMB, with most annual losses in H2.
• Top 10 shareholders highly concentrated, actual control by Liu Yingjian and Xu Dongqing.

III. Risks & Opportunities for Investors

• Continued Heavy Losses and Cash Flow Risk: Three years of losses, negative operating cash. Watch funding chain risk closely.
• High R&D Investment and Commercialization Risk: Frequent innovations but long payback cycles; watch for market acceptance and income conversion.
• Market Expansion Challenges: Paperless signing is saturated in traditional fields; new and overseas markets slow to scale, with growth bottlenecks.
• Policy and Industry Climate Dependency: Many businesses heavily affected by policy and industry bidding; monitor macro changes.
• Brand and Promotion Pressure: Medical brand awareness needs improvement; continued investment in market expansion required.

IV. Conclusion: What Should Investors Do?

Hanvon demonstrates continued innovation in AI, multimodal tech, and industry applications, with robust technical and IP barriers. Yet, ongoing losses, cash flow pressure, and weak growth in some sectors are concerning. If AI product launches succeed and cash improves, shares may be catalyzed. Conversely, ongoing losses, funding pressure, or failed commercialization could pressure the stock. Investors should closely monitor Hanvon’s follow-up operational and financial performance.

Disclaimer: This article is based on Hanvon Technology’s 2025 annual report public information and is for reference only. This does not constitute investment advice. Investment carries risk—invest cautiously.

View 汉王科技 Historical chart here